This is the authors' abstract. We don't add key points for this paper.
Low-HER2 expression did not have any impact on prognosis of metastatic breast cancer in this real-world population.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gampenrieder et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: